Effects of integrin αvβ3on differentiation and collagen synthesis induced by connective tissue growth factor in human hypertrophic scar fibroblasts

International Journal of Molecular Medicine

Volumn 34, Issue 5, 2014, Pages 1323-1334

  Hu, Xiaolong ^a   Li, Na ^a   Tao, Ke ^a   Fang, Xiaobing ^a   Liu, Jiaqi ^a   Wang, Yaojun ^a   Wang, Hongtao ^a   Shi, Jihong ^a   Wang, Yunchuan ^a   Ji, Peng ^a   Cai, Weixia ^a   Bai, Xiaozhi ^a   Zhu, Xiongxiang ^a   Han, Juntao ^a   Hu, Dahai ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Collagen synthesis; Connective tissue growth factor; Differentiation; Hypertrophic scar; Integrin

Indexed keywords

BLOCKING ANTIBODY; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; MESSENGER RNA; VITRONECTIN RECEPTOR; CTGF PROTEIN, HUMAN; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; COLLAGEN SYNTHESIS; CONNECTIVE TISSUE; CONTROLLED STUDY; FIBROBLAST; HYPERTROPHIC SCAR; MUSCLE FIBER CONTRACTION; NONHUMAN; RABBIT; ADULT; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECTS; FEMALE; GENETICS; HUMAN; MALE; METABOLISM; SIGNAL TRANSDUCTION; UPREGULATION; YOUNG ADULT;

ADULT; ANIMALS; CELL DIFFERENTIATION; CICATRIX, HYPERTROPHIC; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; DISEASE MODELS, ANIMAL; FEMALE; FIBROBLASTS; HUMANS; INTEGRIN ALPHAVBETA3; MALE; RABBITS; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; UP-REGULATION; YOUNG ADULT;

EID: 84907218872     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1912     Document Type: Article

References (39)

1. Gauglitz GG, Korting HC, Pavicic T, Ruzicka T and Jeschke MG: Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17: 113-125, 2011.
2. Jun JI and Lau LF: Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov 10: 945-963, 2011.
3. Shi-Wen X, Leask A and Abraham D: Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev 19: 133-144, 2008.
4. de Winter P, Leoni P and Abraham D: Connective tissue growth factor: structure-function relationships of a mosaic, multifunctional protein. Growth Factors 26: 80-91, 2008.
5. Chen CC and Lau LF: Functions and mechanisms of action of CCN matricellular proteins. Int J Biochem Cell Biol 41: 771-783, 2009.
6. Phanish MK, Winn SK and Dockrell ME: Connective tissue growth factor-(CTGF, CCN2)-a marker, mediator and therapeutic target for renal fibrosis. Nephron Exp Nephrol 114: e83-e92, 2010.
7. Hu X, Wang H, Liu J, Fang X, Tao K, Wang Y, Li N, Shi J, Wang Y, Ji P, Cai W, Bai X, Zhu X, Han J and Hu D: The role of ERK and JNK signaling in connective tissue growth factor induced extracellular matrix protein production and scar formation. Arch Dermatol Res 305: 433-445, 2013.
8. Shi-wen X, Stanton LA, Kennedy L, Pala D, Chen Y, Howat SL, Renzoni EA, Carter DE, Bou-Gharios G, Stratton RJ, Pearson JD, Beier F, Lyons KM, Black CM, Abraham DJ and Leask A: CCN2 is necessary for adhesive responses to transforming growth factor-beta1 in embryonic fibroblasts. J Biol Chem 281: 10715-10726, 2006.
9. Colwell AS, Phan TT, Kong W, Longaker MT and Lorenz PH: Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation. Plast Reconstr Surg 116: 1387-1390, 2005.
10. van der Veer WM, Bloemen MC, Ulrich MM, Molema G, van Zuijlen PP, Middelkoop E and Niessen FB: Potential cellular and molecular causes of hypertrophic scar formation. Burns 35: 15-29, 2009.
11. Wang J, Dodd C, Shankowsky HA, Scott PG and Tredget EE; Wound healing research group: Deep dermal fibroblasts contribute to hypertrophic scarring. Lab Invest 88: 1278-1290, 2008.
12. Nakerakanti SS, Bujor AM and Trojanowska M: CCN2 is required for the TGF-ß induced activation of Smad1-Erk1/2 signaling network. PLoS One 6: e21911, 2011.
13. Sisco M, Kryger ZB, O'Shaughnessy KD, Kim PS, Schultz GS, Ding XZ, Roy NK, Dean NM and Mustoe TA: Antisense inhibition of connective tissue growth factor (CCN2/CCN2) mRNA limits hypertrophic scarring without affecting wound healing in vivo. Wound Repair Regen 16: 661-673, 2008.
14. Scaffidi AK, Petrovic N, Moodley YP, Fogel-Petrovic M, Kroeger KM, Seeber RM, Eidne KA, Thompson PJ and Knight DA: Alpha(v)beta(3) integrin interacts with the transforming growth factor beta (TGFbeta) type II receptor to potentiate the proliferative effects of TGFbeta1 in living human lung fibroblasts. J Biol Chem 279: 37726-37733, 2004.
15. Asano Y, Ihn H, Yamane K, Jinnin M, Mimura Y and Tamaki K: Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts. J Immunol 175: 7708-7718, 2005.
16. Cruet-Hennequart S, Maubant S, Luis J, Gauduchon P, Staedel C and Dedhar S: Alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells. Oncogene 22: 1688-1702, 2003.
17. Levinson H, Hopper JE and Ehrlich HP: Overexpression of integrin alphav promotes human osteosarcoma cell populated collagen lattice contraction and cell migration. J Cell Physiol 193: 219-224, 2002.
18. Meerovitch K, Bergeron F, Leblond L, Grouix B, Poirier C, Bubenik M, Chan L, Gourdeau H, Bowlin T and Attardo G: A novel RGD antagonist that targets both alphavbeta3 and alpha5beta1 induces apoptosis of angiogenic endothelial cells on type I collagen. Vascul Pharmacol 40: 77-89, 2003.
19. Trusolino L, Serini G, Cecchini G, Besati C, Ambesi-Impiombato FS, Marchisio PC and De Filippi R: Growth factor-dependent activation of alphavbeta3 integrin in normal epithelial cells: implications for tumor invasion. J Cell Biol 142: 1145-1156, 1998.
20. Liu J, Wang Y, Pan Q, Su Y, Zhang Z, Han J, Zhu X, Tang C and Hu D: Wnt/ß-c-catenin pathway forms a negative feedback loop during TGF-ß1 induced human normal skin fibroblast-to-myofibroblast transition. J Dermatol Sci 65: 38-49, 2012.
21. Shi JH, Guan H, Shi S, Cai WX, Bai XZ, Hu XL, Fang XB, Liu JQ, Tao K, Zhu XX, Tang CW and Hu DH: Protection against TGF-ß1-induced fibrosis effects of IL-10 on dermal fibroblasts and its potential therapeutics for the reduction of skin scarring. Arch Dermatol Res 305: 341-52, 2013.
22. Bell E, Ivarsson B and Merrill C: Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci USA 76: 1274-1278, 1979.
23. Sarrazy V, Billet F, Micallef L, Coulomb B and Desmoulière A: Mechanisms of pathological scarring: role of myofibroblasts and current developments. Wound Repair Regen 19 (Suppl 1): s10-s15, 2011.
24. Gurtner GC, Werner S, Barrandon Y and Longaker MT: Wound repair and regeneration. Nature 453: 314-21 2008.
25. Leask A and Abraham DJ: All in the CCN family: essential matricellular signaling modulators emerge from the bunker. J Cell Sci 119: 4803-4810, 2006.
26. Luft FC: CCN2, the connective tissue growth factor. J Mol Med (Berl) 86: 1-3, 2008.
27. Wang Q, Usinger W, Nichols B, Gray J, Xu L, Seeley TW, Brenner M, Guo G, Zhang W, Oliver N, Lin A and Yeowell D: Cooperative interaction of CCN2 and TGF-ß in animal models of fibrotic disease. Fibrogenesis Tissue Repair 4: 4, 2011.
28. Leask A and Abraham DJ: The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 81: 355-63, 2003.
29. Blom IE, Goldschmeding R and Leask A: Gene regulation of connective tissue growth factor: new targets for antifibrotic therapy? Matrix Biol 21: 473-482, 2002.
30. Igarashi A, Okochi H, Bradham DM and Grotendorst GR: Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell 4: 637-645, 1993.
31. Mori T, Kawara S, Shinozaki M, Hayashi N, Kakinuma T, Igarashi A, Takigawa M, Nakanishi T and Takehara K: Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol 181: 153-159, 1999.
32. Ihn H, Yamane K, Kubo M and Tamaki K: Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: Association with increased expression of transforming growth factor beta receptors. Arthritis Rheum 44: 474-480, 2001.
33. Miller WH, Keenan RM, Willette RN and Lark MW: Identification and in vivo efficacy of small-molecule antagonists of integrin alphavbeta3 (the vitronectin receptor). Drug Discov Today 5: 397-408, 2000.
34. Gao R and Brigstock DR: Connective tissue growth factor (CCN2) induces adhesion of rat activated hepatic stellate cells by binding of its C-terminal domain to integrin alpha(v)beta(3) and heparan sulfate proteoglycan. J Biol Chem 279: 8848-8855, 2004.
35. Blaschuk KL, Guérin C and Holland PC: Myoblast alphav beta3 integrin levels are controlled by transcriptional regulation of expression of the beta3 subunit and down-regulation of beta3 subunit expression is required for skeletal muscle cell differentiation. Dev Biol 184: 266-277, 1997.
36. Milner R, Huang X, Wu J, Nishimura S, Pytela R, Sheppard D and ffrench-Constant C: Distinct roles for astrocyte alphavbeta5 and alphavbeta8 integrins in adhesion and migration. J Cell Sci 112: 4271-4279, 1999.
37. Rodan SB and Rodan GA: Integrin function in osteoclasts. J Endocrinol 154: S47-S56, 1997.
38. Thomas GJ, Lewis MP, Hart IR, Marshall JF and Speight PM: AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int J Cancer 92: 641-650, 2001.
39. Asano Y, Ihn H, Yamane K, Jinnin M and Tamaki K: Increased expression of integrin alphavbeta5 induces the myofibroblastic differentiation of dermal fibroblasts. Am J Pathol 168: 499-510, 2006.